Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation
Jyoti S. Mathad(Cornell University), Amita Gupta(Johns Hopkins University), Bruno B. Andrade(Escola Bahiana de Medicina e Saúde Pública), Breno Santos(Hospital Nossa Senhora da Conceição), Thomas Campbell(University of Colorado Anschutz Medical Campus), Ashwin Balagopal(Johns Hopkins University), James Hakim(University of Zimbabwe), David M. Asmuth(University of California, Davis), Susan E. Cohn(Brigham and Women's Hospital), Nikhil Gupte(Johns Hopkins University), Patcharaphan Sugandhavesa(Chiang Mai University), Sima Berendes(Johns Hopkins University), Rosa Infante(Asociación Civil Impacta Salud y Educación), Judith S. Currier(University of California, Los Angeles), Sandra Wagner Cardoso(Instituto Evandro Chagas), Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Noluthando Mwelase(University of the Witwatersrand), Jyoti Pawar(National AIDS Research Institute), Cynthia Riviere(Hôpital Necker-Enfants Malades), Sandy Pillay(Durban University of Technology), Mina C. Hosseinipour
Cited by 71
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association
|Circulation|2019|639
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
|New England Journal of Medicine|2011|541